Realcan Pharmaceutical Group Co Ltd
SZSE:002589
Realcan Pharmaceutical Group Co Ltd
SZSE:002589
Price:
3.59
CNY
10.12%
Market Cap:
¥5.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Realcan Pharmaceutical Group Co Ltd
SZSE:002589
|
CN |
|
O
|
Old Mutual Ltd
JSE:OMU
|
ZA |
|
Alpha Group Inc
TSE:3322
|
JP |
|
Pfizer Ltd
NSE:PFIZER
|
IN |
|
J
|
Jiangxi Hungpai New Material Co Ltd
SSE:605366
|
CN |
|
F
|
FMS Enterprises Migun Ltd
TASE:FBRT
|
IL |
|
ESR Kendall Square REIT Co Ltd
KRX:365550
|
KR |
|
Tecsys Inc
TSX:TCS
|
CA |
|
D
|
Dongkuk Structures & Construction Co Ltd
KOSDAQ:100130
|
KR |
|
I
|
Isracard Ltd
TASE:ISCD
|
IL |
Multiples-Based Value
The
Multiples-Based Value for
Realcan Pharmaceutical Group Co Ltd (002589)
under the Base Case is
hidden
CNY.
Compared with the current market price of 3.59 CNY, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Realcan Pharmaceutical Group Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Realcan Pharmaceutical Group Co Ltd Competitors
Realcan Pharmaceutical Group Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Realcan Pharmaceutical Group Co Ltd
SZSE:002589
|
5.4B CNY | 0.7 | -893.2 | -181.2 | -181.2 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
106.2B USD | 0.3 | 24.5 | 17.2 | 19.3 | |
| US |
|
Cencora Inc
NYSE:COR
|
61.8B USD | 0.2 | 38.1 | 13.5 | 17 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
62.2B USD | 0.2 | 38.3 | 13.5 | 17.1 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
50B USD | 0.2 | 30.1 | 14.5 | 18.9 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
31.1B AUD | 2.7 | 34.4 | 25.5 | 25.5 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64B CNY | 0.2 | 11.2 | 8.7 | 8.7 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
62.6B CNY | 1.5 | 16.9 | 13.1 | 13.1 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9B USD | 0.7 | 22.5 | 11.1 | 15.6 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65B HKD | 0.1 | 8.1 | 0.7 | 0.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
